Literature DB >> 10841970

Clinical and echocardiographic predictors of left atrial clot and spontaneous echo contrast in patients with severe rheumatic mitral stenosis: a prospective study in 200 patients by transesophageal echocardiography.

K C Goswami1, R Yadav, M B Rao, V K Bahl, K K Talwar, S C Manchanda.   

Abstract

The objective of this study was to prospectively investigate various clinical and echocardiographic variables to predict the left atrial and left atrial appendage clot and spontaneous echo contrast in patients with severe rheumatic mitral stenosis. We studied 200 consecutive patients (112 males and 88 females; mean age 29.6+/-9.6 years). Left atrial clot and spontaneous echo contrast were present in 26 and 53.5% of cases, respectively. There were no significant differences in the mitral valve area, mean transmitral diastolic gradient and left ventricular ejection fraction between patients with and without clot. Patients with clot were older (34.4+/-11.4 vs. 28.2+/-8.5 years, P<0.001), had longer duration of symptoms (41. 4+/-36.0 vs. 28.8+/-22.9 months, P<0.001), more frequent atrial fibrillation and spontaneous echo contrast (69.2 vs. 16.9%, P<0. 00001 and 76.9 vs. 45.3%, P<0.00001, respectively) and larger left atrial area and diameter (41.0+/-12.7 vs. 29.9+/-7.4 cm(2), P<0.00001 and 53.9+/-8.3 vs. 47.6+/-7.4 mm, P<0.0001, respectively) as compared to patients without clot. Similarly patients with spontaneous echo contrast were older (31+/-10.4 vs. 27.8+/-8.3 years, P<0.01), had more frequent atrial fibrillation (48.6 vs. 9.7%, P<0.0001), left atrial clot (37.4 vs. 12.9%, P<0.0001), larger left atrial area and diameter (37.6+/-11.2 vs. 28.1+/-6.7 cm(2), P<0.00001 and 52.2+/-8.3 vs. 45.9+/-6.5 mm, P<0.00001, respectively) and smaller mitral valve area (0.77+/-0.14 vs. 0.84+/-0.13 cm(2), P<0.01) as compared to patients without spontaneous echo contrast. There were no significant differences in the mean transmitral diastolic gradient and left ventricular ejection fraction. On multiple regression and discriminant function analysis, atrial fibrillation and left atrial area were independent predictors of left atrial clot formation. In a subgroup of patients with sinus rhythm, larger left atrial area and presence of spontaneous echo contrast were significantly associated with the presence of clot in left atrium and appendage. We conclude that in patients with severe mitral stenosis, the presence of atrial fibrillation and in the subgroup of the patients with sinus rhythm the presence of large left atrium (> or =40 cm(2)) and spontaneous echo contrast were associated with higher risk of clot formation in the left atrium and might be benefited by prophylactic anticoagulation.

Entities:  

Mesh:

Year:  2000        PMID: 10841970     DOI: 10.1016/s0167-5273(00)00235-7

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  11 in total

1.  Incidence and factors influencing left atrial clot in patients with mitral stenosis and normal sinus rhythm.

Authors:  S J Saidi; M H K Motamedi
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

2.  Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Richard P Whitlock; Jack C Sun; Stephen E Fremes; Fraser D Rubens; Kevin H Teoh
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Association of the CHA2DS2-VASc score with left atrial spontaneous echo contrast: a cross-sectional study of patients with rheumatic mitral stenosis in sinus rhythm.

Authors:  Erdal Belen; Ender Ozal; Hamdi Pusuroglu
Journal:  Heart Vessels       Date:  2015-10-16       Impact factor: 2.037

4.  Detection of left atrial thrombus in patients with mitral stenosis and atrial fibrillation: retrospective comparison of two-phase computed tomography, transoesophageal echocardiography and surgical findings.

Authors:  Bo Hwa Choi; Sung Min Ko; Hweung Kon Hwang; Meong Gun Song; Je Kyoun Shin; Woon Seok Kang; Tae-Yop Kim
Journal:  Eur Radiol       Date:  2013-07-03       Impact factor: 5.315

5.  High levels of high sensitivity C-reactive protein predict the progression of chronic rheumatic mitral stenosis.

Authors:  Omer Alyan; Fatma Metin; Fehmi Kacmaz; Ozcan Ozdemir; Orhan Maden; Serkan Topaloglu; Ahmet Duran Demir; Zulkuf Karahan; Aziz Karadede; Erdogan Ilkay
Journal:  J Thromb Thrombolysis       Date:  2008-07-12       Impact factor: 2.300

6.  Role of LA shape in predicting embolic cerebrovascular events in mitral stenosis: mechanistic insights from 3D echocardiography.

Authors:  Maria Carmo P Nunes; Mark D Handschumacher; Robert A Levine; Marcia M Barbosa; Vinicius T Carvalho; William A Esteves; Xin Zeng; J Luis Guerrero; Hui Zheng; Timothy C Tan; Judy Hung
Journal:  JACC Cardiovasc Imaging       Date:  2014-05

Review 7.  Recent advances in the management of transient ischemic attacks.

Authors:  Camilo R Gomez; Michael J Schneck; Jose Biller
Journal:  F1000Res       Date:  2017-10-26

8.  Predictive factors of left atrial spontaneous echo contrast in patients with rheumatic mitral valve stenosis: a retrospective study of 159 patients.

Authors:  Sanaa Drissi; Hicham Sabor; Ahlam Ounsy; Najat Mouine; Mohamed Sabry; Aatif Benyass; El Mehdi Zbir; Konate Lassana; Naima Elhaithem
Journal:  Int Arch Med       Date:  2014-06-25

9.  The association between mean platelet volume and spontaneous echocardiographic contrast or left atrial thrombus in patients with mitral stenosis.

Authors:  Kevser Gülcihan Balcı; Orhan Maden; Mustafa Mücahit Balcı; Fatih Şen; Sefa Ünal; Serdar Kuyumcu; Meryem Kara; Hatice Selçuk; Mehmet Timur Selcuk; Ahmet Temizhan
Journal:  Anatol J Cardiol       Date:  2016-04-25       Impact factor: 1.596

Review 10.  Meta-Analysis of the Incidence, Prevalence, and Correlates of Atrial Fibrillation in Rheumatic Heart Disease.

Authors:  Jean Jacques Noubiap; Ulrich Flore Nyaga; Aude Laetitia Ndoadoumgue; Jan René Nkeck; Anderson Ngouo; Jean Joel Bigna
Journal:  Glob Heart       Date:  2020-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.